Robert More

Manufactures and supplies pharmaceutical products

Provides diagnostic tests for poor people

Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases

Develops & markets therapeutics for infectious diseases

Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations

Operates as an ophthalmic medical device company

Manufactures and markets medical devices

Develops proprietary drug discovery technology

Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors.

Manufactures and develops drugs

Functions as a College/University

Manufactures and sells medical devices

Develops and markets medical devices

Develops therapies to treat inflammation and neurological diseases

Operates as a network of venture capitalists

Manufactures pharmaceuticals and medical devices

Provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic

Develops medical device treatments

Develops and manufactures medical devices

Functions as a College/University

Foundation Trust-IM holds the endowment, including the annual installments of Warren Buffett’s gift, and funds the foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed, as it has been for almost three decades, by a team of outside investment managers. The Trust invests in undistributed assets, with the exclusive goal of maximizing the return on investment. Investments include companies that have been criticized for worsening poverty in the same developing countries where the foundation is attempting to relieve poverty. The majority of the trust's assets are invested in government and corporate bonds, with additional holdings in commercial paper and other short-term debt securities. The trust engages in substantial foreign currency transactions, options and futures trading and lending out of securities.

Operates as a biotechnology company which develops novel conjugation technology

Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders

Operates as a biotechnology company that provides organs and cells transplantation services

Develops cures and treatments drug for viral & bacterial diseases

Provides healthcare services

Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies

Develops therapeutics for human generic diversity

Develops radiation delivery systems for the treatment of solid cancerous tumor

Provides drug discovery and development services for cancer treatment

Operates as a clinical-stage biotechnology company that develops pipeline of genetic medicines

Operates as a biotechnology company focusing on developing the of medicine